+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding



Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding



American Journal of Gastroenterology 100(4): 797-804



The role of propranolol in addition to EVL in the prevention of first variceal bleed has not been evaluated. This prospective randomized controlled trial compared endoscopic variceal ligation (EVL) with propranolol and EVL alone in the prevention of first variceal bleed among patients with high-risk varices. One hundred and forty-four consecutive patients with high-risk varices were randomly allocated to EVL plus propranolol (Gr I, n = 72) or EVL alone (Gr II, n = 72). EVL was done at 2-wk interval till obliteration of varices. In Gr I, incremental dosage of propranolol (sufficient to reduce heart rate to 55 beats/min or 25% reduction from baseline) was administered and continued after obliteration of varices. The endpoints of the study were bleeding and death. The two groups of patients had comparable baseline characteristics; follow-up (Gr I: 13.1 +/- 11.5 months, Gr II: 11.2 +/- 9.9 months), number of cirrhotic and noncirrhotic portal hypertension patients [Gr I 64 (88.6%) and 8 (11.4%), Gr II 63 (87.5%) and 9 (12.5%)], and frequency of Child's A (15 vs 18), B (38 vs 35), and C (19 vs 19). The mean daily propranolol dose achieved in Gr I was 95.6 +/- 38.6 mg. Eleven patients had bleeds, 5 in Gr I and 6 in Gr II. All patients bled before the obliteration of varices, the actuarial probability of first bleed at 20 months was 7% in Gr I and 11% in Gr II (p= 0.72). Six patients died in the combination and 8 in EVL group. All deaths in Gr I were due to nonbleed-related causes, while in Gr II, 2 deaths were bleed related, the actuarial probability of death at 20 months was 8% and 15%, respectively (p= 0.37). The probability of bleed-related death was comparable (p= 0.15). At the end of follow-up, 4 patients in Gr I and 11 in Gr II had recurrence of varices (p= 0.03). Side effects on propranolol were seen in 22% patients, in 8% it had to be stopped. There were no serious complications of EVL. Both EVL plus propranolol and EVL alone are effective in primary prophylaxis of bleed from high-risk varices. Addition of propranolol does not decrease the probability of first bleed or death in patients on EVL. However, the recurrence of varices is lower if propranolol is added to EVL.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012037038

Download citation: RISBibTeXText

PMID: 15784021

DOI: 10.1111/j.1572-0241.2005.40468.x


Related references

Combination of endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in the primary prophylaxis of oesophageal variceal bleeding An interim analysis. Hepatology 34(4 Pt 2): 534A, 2001

Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis. Journal of Gastroenterology and Hepatology 21(2): 413-419, 2006

Endoscopic variceal ligation (EVL) plus propranolol (P) and isosorbide mononitrate (ISMN) versus EVL alone in secondary prophylaxis of variceal bleeding: A prospective RCT. 2007

Endoscopic variceal ligation combined with argon plasma coagulation versus ligation alone for the secondary prophylaxis of variceal bleeding: a systematic review and meta-analysis. European Journal of Gastroenterology and Hepatology 29(6): 621-628, 2017

Endoscopic variceal band ligation compared with propranolol for prophylaxis of first variceal bleeding. Annals of Hepatology 10(2): 142-149, 2011

Combination of endoscopic variceal ligation and propranolol with endoscopic variceal ligation alone in the prevention of first variceal bleed An interim analysis. Journal of Hepatology 36(Suppl. 1): 197, 2002

Variceal band ligation versus propranolol for primary prophylaxis of variceal bleeding in cirrhosis. Current Gastroenterology Reports 7(3): 175-176, 2005

A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology 33(4): 802-807, 2001

Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Alimentary Pharmacology and Therapeutics 21(4): 347-361, 2005

A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding. European Journal of Gastroenterology and Hepatology 8(4): 337-342, 1996

Endoscopic variceal ligation as primary prophylaxis for oesophageal variceal bleeding at a Malaysian tertiary hospital. Medical Journal of Malaysia 73(6): 361-364, 2018

Endoscopic variceal ligation vs endoscopic variceal sclerotherapy in the management of patients with advanced hepatocellular carcinoma and acute esophageal variceal bleeding. Gastroenterology. 104(4 Suppl.): A943, 1993

The efficacy comparison of carvedilol plus endoscopic variceal ligation and traditional, nonselective β-blockers plus endoscopic variceal ligation in cirrhosis patients for the prevention of variceal rebleeding: a meta-analysis. European Journal of Gastroenterology and Hepatology 31(12): 1518-1526, 2019

Sa1596 Efficacy and Safety of Endoscopic Variceal Ligation (EVL) for Primary and Secondary Prophylaxis of Esophageal Variceal Bleeding in an Underserved Population. Gastroenterology 150(4): S337-S338, 2016

A new “sandwich method of combined endoscopic variceal ligation and sclerotherapy versus ligation alone in the treatment of esophageal variceal bleeding A randomized trial. Gastrointestinal Endoscopy 53(6): 572-578, 2001